PL2081926T3 - Wytwarzanie i oczyszczanie mupirocyny wapniowej - Google Patents

Wytwarzanie i oczyszczanie mupirocyny wapniowej

Info

Publication number
PL2081926T3
PL2081926T3 PL07801968T PL07801968T PL2081926T3 PL 2081926 T3 PL2081926 T3 PL 2081926T3 PL 07801968 T PL07801968 T PL 07801968T PL 07801968 T PL07801968 T PL 07801968T PL 2081926 T3 PL2081926 T3 PL 2081926T3
Authority
PL
Poland
Prior art keywords
mupirocin
purification
preparation
calcium
resin
Prior art date
Application number
PL07801968T
Other languages
English (en)
Inventor
Lene Aassveen
Original Assignee
Syngen Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngen Biotech Co Ltd filed Critical Syngen Biotech Co Ltd
Publication of PL2081926T3 publication Critical patent/PL2081926T3/pl

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL07801968T 2006-08-30 2007-08-29 Wytwarzanie i oczyszczanie mupirocyny wapniowej PL2081926T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0617069A GB2441328A (en) 2006-08-30 2006-08-30 A method for obtaining mupirocin calcium
EP07801968A EP2081926B1 (en) 2006-08-30 2007-08-29 Preparation and purification of mupirocin calcium
PCT/EP2007/007547 WO2008025534A1 (en) 2006-08-30 2007-08-29 Preparation and purification of mupirocin calcium

Publications (1)

Publication Number Publication Date
PL2081926T3 true PL2081926T3 (pl) 2012-12-31

Family

ID=37137032

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07801968T PL2081926T3 (pl) 2006-08-30 2007-08-29 Wytwarzanie i oczyszczanie mupirocyny wapniowej

Country Status (12)

Country Link
US (1) US7868191B2 (pl)
EP (1) EP2081926B1 (pl)
JP (1) JP5277167B2 (pl)
CN (1) CN101511826B (pl)
AT (1) ATE556073T1 (pl)
AU (1) AU2007291508B2 (pl)
CA (1) CA2649758C (pl)
GB (1) GB2441328A (pl)
NO (1) NO342269B1 (pl)
PL (1) PL2081926T3 (pl)
TW (1) TWI406860B (pl)
WO (1) WO2008025534A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2441328A (en) 2006-08-30 2008-03-05 Alpharma Aps A method for obtaining mupirocin calcium
CN101591333B (zh) * 2009-07-02 2012-01-04 山东健威生物工程有限公司 一种提纯假单胞菌酸a的方法
CN104370896A (zh) * 2013-11-29 2015-02-25 江苏汉邦科技有限公司 一种纯化假单孢菌素的方法
EP4190780A4 (en) * 2020-08-25 2024-03-20 Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. MUPIROCIN EXTRACTION PROCESS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071536A (en) * 1971-06-12 1978-01-31 Beecham Group Limited Antibiotics
GB1395907A (en) * 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
US3977943A (en) * 1971-06-12 1976-08-31 Beecham Group Limited Antibiotics
CA1103264A (en) 1977-09-30 1981-06-16 Norman H. Rogers Purification of pseudomonic acid
CA1115699A (en) * 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
JPH01268682A (ja) * 1988-04-21 1989-10-26 Minofuaagen Seiyaku Honpo:Goushi 腎機能改善剤及びリソスペルミン酸塩の製造方法
US5235037A (en) * 1991-08-15 1993-08-10 American Cyanamid Company Vancomycin precipitation process
HUP0105286A3 (en) * 1999-02-03 2003-03-28 Biogal Gyogyszergyar Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth
HRP20040642A2 (en) * 2001-12-28 2005-10-31 Teva Gy�gyszergy�r R�szv�nyt�rsas�g Processes for preparing crystalline and amorphous mupirocin calcium
US7589128B2 (en) * 2004-06-01 2009-09-15 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparation of amorphous form of a drug
AU2006215708B2 (en) * 2005-02-21 2011-01-27 Syngen Biotech Co., Ltd Purification of mupirocin
GB2441328A (en) 2006-08-30 2008-03-05 Alpharma Aps A method for obtaining mupirocin calcium

Also Published As

Publication number Publication date
CA2649758C (en) 2014-03-18
JP5277167B2 (ja) 2013-08-28
NO20091293L (no) 2009-03-27
CN101511826B (zh) 2011-06-22
ATE556073T1 (de) 2012-05-15
WO2008025534A1 (en) 2008-03-06
JP2010501608A (ja) 2010-01-21
CA2649758A1 (en) 2008-03-06
AU2007291508B2 (en) 2011-11-24
US7868191B2 (en) 2011-01-11
TWI406860B (zh) 2013-09-01
CN101511826A (zh) 2009-08-19
GB2441328A (en) 2008-03-05
GB0617069D0 (en) 2006-10-11
US20090240071A1 (en) 2009-09-24
EP2081926B1 (en) 2012-05-02
AU2007291508A1 (en) 2008-03-06
EP2081926A1 (en) 2009-07-29
TW200825070A (en) 2008-06-16
NO342269B1 (no) 2018-04-30

Similar Documents

Publication Publication Date Title
ZA200903526B (en) Process for producing a purified synthesis gas stream
FR2882941B1 (fr) Procede de purification d'un gaz naturel par adsorption des mercaptans
MX2007007682A (es) Proceso para depurar polioles polimericos.
WO2008134048A3 (en) Methods for synthesizing and purifying aminoalkyl tetracycline compounds
EP2007687A4 (en) HYBRID MEMBRANE MODULE AND INDUSTRIAL PROCESSING SYSTEM AND METHOD USING THE SAME
MY160860A (en) Natural gas purification system
ZA200610740B (en) Process for fine purification of 1-butenic streams
MX2009006307A (es) Adsorbente de fosfato a base de hierro (iii)-carbohidrato.
BRPI0803056A2 (pt) método e instalação para a purificação de gás
MY150516A (en) Contaminant removal from a gas stream
EG25734A (en) Process for the purification of an aqueous stream coming from the fischer-tropisch reaction
WO2007016635A3 (en) Process for the purification of coenzyme q10
IL187935A0 (en) Process for the purification of il-18 binding protein
BR102018069428A2 (pt) processos melhorados que usam composições adsorventes de rho
ATE556073T1 (de) Herstellung und reinigung von mupirocin-calcium
WO2011053034A3 (ko) 생물 활성탄과 입상 활성탄을 이용한 정수 시스템 및 정수 방법
FR2940647B1 (fr) Procede et installation de traitement d'une phase aqueuse contenant un materiau adsorbant usite
PL1841863T3 (pl) Sposób oczyszczania czynnika VII
TW200738622A (en) Process for purifying (meth)acrylates
EP1942078A4 (en) METHOD FOR CLEANING SILICONE APPLICATIONS, CLEANERS AND CLEANED SILICA PARTICLES
SG169979A1 (en) Accelerating agent of calcium absorption
TN2010000289A1 (en) Wastewater treatment installation and method of treating wastewater
WO2009057137A3 (en) A process for the purification of levetiracetam
EP1867604A4 (en) PROCESS FOR CLEANING DISILICATE HEXACHLORIDE AND HIGH-PURITY DISILICON HEXACHLORIDE
MX2013013224A (es) Procedimiento de purificacion de proteinas de bajo ph.